Clinical Trial
Clinical effects of naltrexone on autistic behavior
Affiliations
- PMID: 1497864
Item in Clipboard
Clinical Trial
Clinical effects of naltrexone on autistic behavior
Am J Ment Retard.
1992 Jul.
Abstract
Eight young adults who were diagnosed with autism were given the opiate antagonist naltrexone to control self-injurious behavior and maladaptive idiosyncratic mannerisms. The drug and placebo were administered in a double-blind crossover design over 17 weeks. Although one subject appeared to have partial decreases in maladaptive behaviors associated with naltrexone use, the drugs, as administered in this study, did not reduce the self-injurious and other maladaptive behaviors of the subjects.
Similar articles
-
Naltrexone in autistic children: behavioral symptoms and attentional learning.J Am Acad Child Adolesc Psychiatry. 1993 Nov;32(6):1283-91. doi: 10.1097/00004583-199311000-00024. J Am Acad Child Adolesc Psychiatry. 1993. PMID: 8282676 Clinical Trial.
-
Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally retarded adults. Double-blind placebo-controlled studies.Arch Gen Psychiatry. 1995 Sep;52(9):766-73. doi: 10.1001/archpsyc.1995.03950210060011. Arch Gen Psychiatry. 1995. PMID: 7654128 Clinical Trial.
-
Efficacy and safety of naltrexone use in pediatric patients with autistic disorder.Ann Pharmacother. 2006 Jun;40(6):1086-95. doi: 10.1345/aph.1G499. Epub 2006 May 30. Ann Pharmacother. 2006. PMID: 16735648 Review.
-
Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study.J Am Acad Child Adolesc Psychiatry. 1995 Feb;34(2):223-31. doi: 10.1097/00004583-199502000-00018. J Am Acad Child Adolesc Psychiatry. 1995. PMID: 7896655 Clinical Trial.
-
[Opiate hypothesis in infantile autism? Therapeutic trials with naltrexone].Encephale. 1993 Mar-Apr;19(2):95-102. Encephale. 1993. PMID: 8275903 Review. French.
Cited by
-
Risk factors associated with self-injurious behaviors in children and adolescents with autism spectrum disorders.J Autism Dev Disord. 2012 Nov;42(11):2460-70. doi: 10.1007/s10803-012-1497-9. J Autism Dev Disord. 2012. PMID: 22422338
-
The Potential Role of Naltrexone in Borderline Personality Disorder.Iran J Psychiatry. 2017 Apr;12(2):142-146. Iran J Psychiatry. 2017. PMID: 28659987 Free PMC article.
-
Pharmacological intervention for irritability, aggression, and self-injury in autism spectrum disorder (ASD).Cochrane Database Syst Rev. 2023 Oct 9;10(10):CD011769. doi: 10.1002/14651858.CD011769.pub2. Cochrane Database Syst Rev. 2023. PMID: 37811711 Free PMC article.
-
Pharmacological interventions for self-injurious behaviour in adults with intellectual disabilities.Cochrane Database Syst Rev. 2013 Apr 30;2013(4):CD009084. doi: 10.1002/14651858.CD009084.pub2. Cochrane Database Syst Rev. 2013. PMID: 23633366 Free PMC article.
-
The cyclic AMP phenotype of fragile X and autism.Neurosci Biobehav Rev. 2008 Oct;32(8):1533-43. doi: 10.1016/j.neubiorev.2008.06.005. Epub 2008 Jun 17. Neurosci Biobehav Rev. 2008. PMID: 18601949 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical